{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:43:06Z","timestamp":1788864186380,"version":"build-2803163510"},"reference-count":42,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0264","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:14:47Z","timestamp":1745414087000},"source":"Crossref","is-referenced-by-count":3,"title":["Arrhythmogenic right ventricular cardiomyopathy"],"prefix":"10.3238","author":[{"given":"Fabienne","family":"Kreimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardan M.","family":"Saguner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Milting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"10.3238\/arztebl.m2024.0264_ref1","doi-asserted-by":"crossref","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al.: 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44: 3503\u2013626.","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"10.3238\/arztebl.m2024.0264_ref2","doi-asserted-by":"crossref","unstructured":"Corrado D, Perazzolo Marra M, Zorzi A, et al.: Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol 2020; 319: 106\u201314.","DOI":"10.1016\/j.ijcard.2020.06.005"},{"key":"10.3238\/arztebl.m2024.0264_ref3","doi-asserted-by":"crossref","unstructured":"Migliore F, Zorzi A, Michieli P, et al.: Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation 2012; 125: 529\u201338.","DOI":"10.1161\/CIRCULATIONAHA.111.055673"},{"key":"10.3238\/arztebl.m2024.0264_ref4","doi-asserted-by":"crossref","unstructured":"Bosman LP, Sammani A, James CA, et al.: Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis. Heart Rhythm 2018; 15: 1097\u2013107.","DOI":"10.1016\/j.hrthm.2018.01.031"},{"key":"10.3238\/arztebl.m2024.0264_ref5","doi-asserted-by":"crossref","unstructured":"Bhonsale A, Groeneweg JA, James CA, et al.: Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart J 2015; 36: 847\u201355.","DOI":"10.1093\/eurheartj\/ehu509"},{"key":"10.3238\/arztebl.m2024.0264_ref6","doi-asserted-by":"crossref","unstructured":"Protonotarios A, Anastasakis A, Panagiotakos DB, et al.: Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. Europace 2016; 18: 610\u20136.","DOI":"10.1093\/europace\/euv061"},{"key":"10.3238\/arztebl.m2024.0264_ref7","doi-asserted-by":"crossref","unstructured":"Marcus FI, McKenna WJ, Sherrill D, et al.: Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: Proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806\u201314.","DOI":"10.1093\/eurheartj\/ehq025"},{"key":"10.3238\/arztebl.m2024.0264_ref8","doi-asserted-by":"crossref","unstructured":"Bosman LP, Cadrin-Tourigny J, Bourfiss M, et al.: Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: Clinical performance and simplified practical implementation. Europace 2020; 22: 787\u201396.","DOI":"10.1093\/europace\/euaa039"},{"key":"10.3238\/arztebl.m2024.0264_ref9","doi-asserted-by":"crossref","unstructured":"Platonov PG, Calkins H, Hauer RN, et al.: High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Heart Rhythm 2016; 13: 208\u201316.","DOI":"10.1016\/j.hrthm.2015.08.031"},{"key":"10.3238\/arztebl.m2024.0264_ref10","doi-asserted-by":"crossref","unstructured":"Gasperetti A, Cappelletto C, Carrick R, et al.: Association of premature ventricular contraction burden on serial holter monitoring with arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy. JAMA Cardiol 2022; 7: 378\u201385.","DOI":"10.1001\/jamacardio.2021.6016"},{"key":"10.3238\/arztebl.m2024.0264_ref11","doi-asserted-by":"crossref","unstructured":"Brosnan MJ, Te Riele ASJM, Bosman LP, et al.: Electrocardiographic features differentiating arrhythmogenic right ventricular cardiomyopathy from an athlete\u2018s heart. JACC Clin Electrophysiol 2018; 4: 1613\u201325.","DOI":"10.1016\/j.jacep.2018.09.008"},{"key":"10.3238\/arztebl.m2024.0264_ref12","doi-asserted-by":"crossref","unstructured":"Cipriani A, Bauce B, Lazzari M de, et al.: Arrhythmogenic right ventricular cardiomyopathy: Characterization of left ventricular phenotype and differential diagnosis with dilated cardiomyopathy. J Am Heart Assoc 2020; 9: e014628.","DOI":"10.1161\/JAHA.119.014628"},{"key":"10.3238\/arztebl.m2024.0264_ref13","doi-asserted-by":"crossref","unstructured":"Finocchiaro G, Papadakis M, Robertus JL, et al.: Etiology of sudden death in sports: Insights from a United Kingdom regional registry. J Am Coll Cardiol 2016; 67: 2108\u201315.","DOI":"10.1016\/j.jacc.2016.02.062"},{"key":"10.3238\/arztebl.m2024.0264_ref14","doi-asserted-by":"crossref","unstructured":"Gasperetti A, James CA, Cerrone M, Delmar M, Calkins H, Duru F: Arrhythmogenic right ventricular cardiomyopathy and sports activity: From molecular pathways in diseased hearts to new insights into the athletic heart mimicry. Eur Heart J 2021; 42(13): 1231\u201343.","DOI":"10.1093\/eurheartj\/ehaa821"},{"key":"10.3238\/arztebl.m2024.0264_ref15","doi-asserted-by":"crossref","unstructured":"Krahn AD, Wilde AAM, Calkins H, et al.: Arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol 2022; 8: 533\u201353.","DOI":"10.1016\/j.jacep.2021.12.002"},{"key":"10.3238\/arztebl.m2024.0264_ref16","doi-asserted-by":"crossref","unstructured":"Corrado D, Wichter T, Link MS, et al.: Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: An international task force consensus statement. Circulation 2015; 132: 441\u201353.","DOI":"10.1161\/CIRCULATIONAHA.115.017944"},{"key":"10.3238\/arztebl.m2024.0264_ref17","doi-asserted-by":"crossref","unstructured":"Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G: Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959\u201363.","DOI":"10.1016\/j.jacc.2003.03.002"},{"key":"10.3238\/arztebl.m2024.0264_ref18","doi-asserted-by":"crossref","unstructured":"Bosman LP, Wang W, Lie \u00d8H, et al.: Integrating exercise into personalized ventricular arrhythmia risk prediction in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2022; 15: e010221.","DOI":"10.1161\/CIRCEP.121.010221"},{"key":"10.3238\/arztebl.m2024.0264_ref19","doi-asserted-by":"crossref","unstructured":"Costa S, Koch K, Gasperetti A, et al.: Changes in exercise capacity and ventricular function in arrhythmogenic right ventricular cardiomyopathy: The impact of sports restriction during follow-up. J Clin Med 2022; 11: 1150.","DOI":"10.3390\/jcm11051150"},{"key":"10.3238\/arztebl.m2024.0264_ref20","doi-asserted-by":"crossref","unstructured":"Lie \u00d8H, Dejgaard LA, Saberniak J, et al.: Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol 2018; 4: 744\u201353.","DOI":"10.1016\/j.jacep.2018.01.010"},{"key":"10.3238\/arztebl.m2024.0264_ref21","doi-asserted-by":"crossref","unstructured":"El-Battrawy I, Zhao Z, Lan H, et al.: Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. Europace 2018; 20: f46-f56.","DOI":"10.1093\/europace\/euy042"},{"key":"10.3238\/arztebl.m2024.0264_ref22","doi-asserted-by":"crossref","unstructured":"James CA, Bhonsale A, Tichnell C, et al.: Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013; 62: 1290\u20137.","DOI":"10.1016\/j.jacc.2013.06.033"},{"key":"10.3238\/arztebl.m2024.0264_ref23","doi-asserted-by":"crossref","unstructured":"Wang W, Tichnell C, Murray BA, et al.: Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients. Europace 2020; 22: 1270\u20138.","DOI":"10.1093\/europace\/euaa105"},{"key":"10.3238\/arztebl.m2024.0264_ref24","doi-asserted-by":"crossref","unstructured":"Cappelletto C, Gregorio C, Barbati G, et al.: Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy. Int J Cardiol 2021; 334: 58\u201364.","DOI":"10.1016\/j.ijcard.2021.04.069"},{"key":"10.3238\/arztebl.m2024.0264_ref25","doi-asserted-by":"crossref","unstructured":"Gasperetti A, Targetti M, Olivotto I: Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration. Int J Cardiol 2021; 338: 150\u20131.","DOI":"10.1016\/j.ijcard.2021.06.009"},{"key":"10.3238\/arztebl.m2024.0264_ref26","doi-asserted-by":"crossref","unstructured":"Ermakov S, Gerstenfeld EP, Svetlichnaya Y, Scheinman MM: Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2017; 14: 564\u20139.","DOI":"10.1016\/j.hrthm.2016.12.010"},{"key":"10.3238\/arztebl.m2024.0264_ref27","doi-asserted-by":"crossref","unstructured":"Rolland T, Badenco N, Maupain C, et al.: Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy. Europace 2022; 24: 278\u201384.","DOI":"10.1093\/europace\/euab182"},{"key":"10.3238\/arztebl.m2024.0264_ref28","doi-asserted-by":"crossref","unstructured":"Cadrin-Tourigny J, Bosman LP, Nozza A, et al.: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2022; 43: e1\u2013e9.","DOI":"10.1093\/eurheartj\/ehac562"},{"key":"10.3238\/arztebl.m2024.0264_ref29","doi-asserted-by":"crossref","unstructured":"Gasperetti A, Carrick RT, Costa S, et al.: Programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy: a multinational study. Circulation 2022; 146: 1434\u201343.","DOI":"10.1161\/CIRCULATIONAHA.122.060866"},{"key":"10.3238\/arztebl.m2024.0264_ref30","doi-asserted-by":"crossref","unstructured":"Shaheen N, Shaheen A, Elmasry M, Nashwan AJ: Endocardial-epicardial catheter ablation versus endocardial catheter ablation alone for ventricular arrhythmia in patients with structural heart disease (meta-analysis of reconstructed time-to-event data). Am J Cardiol 2023; 201: 185\u201392.","DOI":"10.1016\/j.amjcard.2023.05.068"},{"key":"10.3238\/arztebl.m2024.0264_ref31","doi-asserted-by":"crossref","unstructured":"Gandjbakhch E, Laredo M, Berruezo A, et al.: Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. Europace 2021; 23: 1428\u201336.","DOI":"10.1093\/europace\/euab172"},{"key":"10.3238\/arztebl.m2024.0264_ref32","doi-asserted-by":"crossref","unstructured":"Christiansen MK, Haugaa KH, Svensson A, et al.: Incidence, predictors, and success of ventricular tachycardia catheter ablation in arrhythmogenic right ventricular cardiomyopathy (from the Nordic ARVC Registry). Am J Cardiol 2020; 125: 803\u201311.","DOI":"10.1016\/j.amjcard.2019.11.026"},{"key":"10.3238\/arztebl.m2024.0264_ref33","doi-asserted-by":"crossref","unstructured":"Laredo M, Da Oliveira Silva L, Extramiana F, et al.: Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2020; 17: 41\u20138.","DOI":"10.1016\/j.hrthm.2019.06.022"},{"key":"10.3238\/arztebl.m2024.0264_ref34","doi-asserted-by":"crossref","unstructured":"Zeppenfeld K, Tfelt-Hansen J, Riva M de, et al.: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022; 43: 3997\u20134126.","DOI":"10.1093\/eurheartj\/ehac699"},{"key":"10.3238\/arztebl.m2024.0264_ref35","doi-asserted-by":"crossref","unstructured":"K\u00f6nemann H, Dagres N, Merino JL, et al.: Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. Europace 2023; 25.: euad091.","DOI":"10.1093\/europace\/euad091"},{"key":"10.3238\/arztebl.m2024.0264_ref36","doi-asserted-by":"crossref","unstructured":"Migliore F, Viani S, Bongiorni MG, et al.: Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: results from an Italian multicenter registry. Int J Cardiol 2019; 280: 74\u20139.","DOI":"10.1016\/j.ijcard.2019.01.041"},{"key":"10.3238\/arztebl.m2024.0264_ref37","doi-asserted-by":"crossref","unstructured":"Orgeron GM, Bhonsale A, Migliore F, et al.: Subcutaneous implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: A transatlantic experience. J Am Heart Assoc 2018; 7: e008782.","DOI":"10.1161\/JAHA.118.008782"},{"key":"10.3238\/arztebl.m2024.0264_ref38","doi-asserted-by":"crossref","unstructured":"Gasperetti A, Schiavone M, Milstein J, et al.: Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry. Heart Rhythm 2024; 21: 410\u20138.","DOI":"10.1016\/j.hrthm.2023.12.007"},{"key":"10.3238\/arztebl.m2024.0264_ref39","doi-asserted-by":"crossref","unstructured":"Rudic B, T\u00fcl\u00fcmen E, Berlin V, et al.: Low prevalence of inappropriate shocks in patients with inherited arrhythmia syndromes with the subcutaneous implantable defibrillator single center experience and long-term follow-up. J Am Heart Assoc 2017; 6: e006265.","DOI":"10.1161\/JAHA.117.006265"},{"key":"10.3238\/arztebl.m2024.0264_ref40","doi-asserted-by":"crossref","unstructured":"Honarbakhsh S, Protonotarios A, Monkhouse C, Hunter RJ, Elliott PM, Lambiase PD: Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion. Europace 2023; 25: euad073.","DOI":"10.1093\/europace\/euad073"},{"key":"10.3238\/arztebl.m2024.0264_ref41","doi-asserted-by":"crossref","unstructured":"Bradford WH, Zhang J, Gutierrez-Lara EJ, et al.: Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics. Nat Cardiovasc Res 2023; 2: 1246\u201361.","DOI":"10.1038\/s44161-023-00370-3"},{"key":"10.3238\/arztebl.m2024.0264_ref42","doi-asserted-by":"crossref","unstructured":"van Opbergen CJM, Narayanan B, Sacramento CB, et al.: AAV-mediated delivery of plakophilin-2a arrests progression of arrhythmogenic right ventricular cardiomyopathy in murine hearts: Preclinical evidence supporting gene therapy in humans. Circ Genom Precis Med 2024; 17: e004305.","DOI":"10.1161\/CIRCGEN.123.004305"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:15:17Z","timestamp":1745414117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":42,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0264","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}